The Public Interest and Competition-Based Scrutiny of Mergers: Lessons from the Evolution of Merger Control in the United Kingdom

This article is part of a Chronicle. See more from this Chronicle

Alex Chisholm, Nelson Jung, Oct 15, 2014

Developments over the past few months have been described as a “volcanic rise in protectionist sentiments from national governments.” General Electric’s bid for Alstom as well as numerous recent takeover proposals in the pharmaceutical sector, in particular Pfizer’s attempt to acquire AstraZeneca and AbbVie’s proposed takeover of Shire, have reinvigorated the long-running debate about greater state intervention in cross-border deal-making. There have been calls for a widenin…

ACCESS TO THIS ARTICLE IS RESTRICTED TO SUBSCRIBERS

Please sign in or join us
to access premium content!